Back to Journals » OncoTargets and Therapy » Volume 3 » default

OncoTargets and Therapy

ISSN: 1178-6930

Archive: Volume 3, 2010

Survivin-T34A: molecular mechanism and therapeutic potential

Jonathan R Aspe, Nathan R Wall

OncoTargets and Therapy 2010, 3:247-254

Published Date: 6 December 2010

The spectrum of use of rituximab in chronic lymphocytic leukemia

Alessandra Tedeschi, Eleonora Vismara, Francesca Ricci, et al

OncoTargets and Therapy 2010, 3:227-246

Published Date: 26 November 2010

Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells

Borhane Annabi, Eric Vaillancourt-Jean, Alexander G Weil, et al

OncoTargets and Therapy 2010, 3:219-226

Published Date: 15 November 2010

Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial

Peter D Beitsch, Rakesh R Patel, John D Lorenzetti, et al

OncoTargets and Therapy 2010, 3:211-218

Published Date: 29 October 2010

Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics

Kimbach Tran Carpiuc, Gianantonio Rosti, Fausto Castagnetti, et al

OncoTargets and Therapy 2010, 3:205-210

Published Date: 11 October 2010

Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study

William C Dooley, John P Thropay, Gary J Schreiber, et al

OncoTargets and Therapy 2010, 3:197-203

Published Date: 21 September 2010

Profile of temsirolimus in the treatment of advanced renal cell carcinoma

Michael Staehler, Nicolas Haseke, Wael Khoder, et al

OncoTargets and Therapy 2010, 3:191-196

Published Date: 15 September 2010

The bevacizumab experience in advanced renal cell carcinoma

Lauren C Harshman, Sandy Srinivas

OncoTargets and Therapy 2010, 3:179-189

Published Date: 15 September 2010

Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma

Nousheen Samad, Anas Younes

OncoTargets and Therapy 2010, 3:167-178

Published Date: 6 September 2010

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

Steven E McCormack, Erica D Warlick

OncoTargets and Therapy 2010, 3:157-165

Published Date: 22 July 2010

New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib

C Lance Cowey, Guru Sonpavde, Thomas E Hutson

OncoTargets and Therapy 2010, 3:147-155

Published Date: 20 September 2010

Temozolomide in malignant glioma

Gregor Dresemann

OncoTargets and Therapy 2010, 3:139-146

Published Date: 21 July 2010

Dynamic changes to survivin subcellular localization are initiated by DNA damage

Maritess Gay Asumen, Tochukwu V Ifeacho, Luke Cockerham, et al

OncoTargets and Therapy 2010, 3:129-137

Published Date: 1 July 2010

Current and emerging therapies for the treatment of pancreatic cancer

Rebecca A Moss, Clifton Lee

OncoTargets and Therapy 2010, 3:111-127

Published Date: 14 July 2010

A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency

Mariam Hammadi, Jacques-Olivier Pers, Christian Berthou, et al

OncoTargets and Therapy 2010, 3:99-109

Published Date: 15 June 2010

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

Victoria Bolós, Joan Manuel Gasent, Sara López-Tarruella, et al

OncoTargets and Therapy 2010, 3:83-97

Published Date: 15 June 2010

Anti-angiogenesis therapies: their potential in cancer management

Andrew Eichholz, Shairoz Merchant, Andrew M Gaya

OncoTargets and Therapy 2010, 3:69-82

Published Date: 4 May 2010

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab

Carmen Diana Schweighofer, Clemens-Martin Wendtner

OncoTargets and Therapy 2010, 3:53-67

Published Date: 30 March 2010

Update on options for treatment of metastatic castration-resistant prostate cancer

Prakash Vishnu, Winston W Tan

OncoTargets and Therapy 2010, 3:39-51

Published Date: 23 March 2010

New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab

Argirios Moustakas, Teri N Kreisl

OncoTargets and Therapy 2010, 3:27-38

Published Date: 11 March 2010

CTLA-4 blockade: therapeutic potential in cancer treatments

Ahmad A Tarhini, Fatima Iqbal

OncoTargets and Therapy 2010, 3:15-25

Published Date: 1 March 2010

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes

Jacqueline S Garcia, Nitin Jain, Lucy A Godley

OncoTargets and Therapy 2010, 3:1-13

Published Date: 25 February 2010